OMX30 1 507 -0,4%  OMXH25 3 645 -0,6%  OMXC20 893 -0,5%  Dow 19 827 -0,3%  Nas 5 045 -0,3%  EUR 9,5182 0,2%  USD 8,8829 -0,8%  Olja 55,5 -0,3%  Guld 1 217 0,3% 

Pfizer Aktie

284,50SEK -8,00SEK -2,74%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Pfizer

2015 2016e 2017e 2018e 2019e
Utdelning 1,12 1,20 1,26 1,46 1,42
Direktavkastning (i %) 3,45 3,68 3,89 4,49 4,36
PE-tal 14,77 13,44 12,46 11,41 11,12
Resultat/aktie 2,20 2,42 2,61 2,85 2,93
ytterligare nyheter

Analyser om Pfizer Inc.

Dec, 19 2016 Pfizer Hold Jefferies & Company Inc.
Nov, 29 2016 Pfizer Overweight Barclays Capital
Nov, 11 2016 Pfizer Hold Jefferies & Company Inc.
Nov, 03 2016 Pfizer Overweight Atlantic Equities
Nov, 01 2016 Pfizer Outperform Bernstein Research
ytterligare analyser

Pfizer Peer Group

Abbott Laboratories 40,89
-0,1%
Alexion Pharmaceuticals 135,29
-1,1%
AstraZeneca 506,50
1,0%
Bayer 100,45
-0,6%
Celgene 114,93
-2,2%
EVOTEC 7,65
-1,0%
Gilead Sciences 71,85
-1,7%
GlaxoSmithKline 15,52
-1,8%
Johnson & Johnson 114,85
0,2%
Merck 61,47
-1,4%
Merck 102,20
0,2%
MorphoSys 48,00
-0,8%
Mylan 37,05
0,9%
Novartis 71,35
-1,0%
Pfizer 32,05
-1,4%
Roche 239,70
-0,2%
STADA Arzneimittel 48,25
-0,2%
Sanofi 76,12
-0,9%
Teva Pharmaceutical Industries 33,75
-0,6%
Vertex Pharmaceuticals 81,55
-1,9%
pagehit

Lägg till instrument

Vad tycker du?

Profil Pfizer Inc.

till bolagsprofilen
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles H. Erhart Jr. in 1849 and is headquartered in New York, NY.

Realtidskurs Pfizer Inc.

Bid
31,78
USD
Ask
32,20
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Pfizer Inc. i SEKPUSH CHART

Kurs 284,50 SEK -8,00 -2,74 %
Kurstid 17:29:46
Datum 17.01.2017
Öppning 291,00
Gårdagen 292,50
Dagshögsta 291,00
Dagslägsta 283,50
52 v. högsta 320,00
52 v. lägsta 235,00
52 v. perf.
Volym (Antal) 4 246
Börsvärde (SEK) 1 773,60 Mrd
Börsen

Till aktien Pfizer

Ticker PFE
ISIN US7170811035
Index Dow Jones, S&P 500, S&P 100, NYSE US 100, BX Swiss - USA

Struktuerarde produkter på Pfizer

Produkttyp Antal
Mini Futures 3

Pfizer Nyckeltal

Börsvärde i SEK 1 773,60 Mrd
Free float % 99,94
Antal aktier mio. 6 068,36
Cashflow/aktie i lokal valuta 2,20
Bokvärde/aktie i lokal valuta 10,34
60 dagar vola 26,92
PBV 3,14

Pfizer Historiska kurser

2017-01-16 292,50 1 624
2017-01-13 289,50 4 666
2017-01-12 289,00 7 080
2017-01-11 298,50 2 271
2017-01-10 302,00 4 884

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 563,6 %
Exelixis Inc. 352,6 %
Ariad Pharmaceuticals Inc. 348,7 %
Amylin Pharmaceuticals Inc. 264,9 %
Array BioPharma Inc. 246,5 %